Volume : 08, Issue : 12, December – 2021
Title:
29.FREQUENCY OF CELIAC DISEASE IN TYPE 1 DIABETIC ADULTS
Authors :
Dr. Maham Ejaz Malik, Dr. Muhammad Saleem, Dr. Syeda Maria Bukhari
Abstract :
Objectives: Celiac disease, an autoimmune disease, is related to immune mediated intolerance to gluten. Some studies suggest that Celiac Disease was 20 times more frequent in type 1 patients with diabetes. The objective of our study was to evaluate the prevalence of celiac disease in hospital based type 1 diabetic adults.
Methods: Our study was carried out retrospectively in Services Hospital, Lahore between 2019–2020. The cohort comprised 482 type 1 patients with diabetes attending the diabetes outpatient clinic. The data were analyzed by SPSS 10.5 package program. Student’s t tests is used for comparative analyses. A p-value less than 0.05 was considered statistically significant.
Results: The cohort included 482 type 1 patients with diabetes. Fifty seven of them were not evaluated for Endomysium antibody positivity. Fifteen of the remaining 425 patients were positive for anti endomysial antibody (3.5%). The prevalence of biopsy proven celiac disease was 2.3% (10/425). There was no significant difference between Endomysial antibody positive and negative groups in regard of age, sex, or duration of the disease.
Conclusion: This study confirms that the celiac disease is common in type 1 diabetic patients. Since a small proportion of celiac patients are symptomatic this disorder should be screened in all adult type 1 patients with diabetes by antiendomysium antibody.
Cite This Article:
Please cite this article in press Maham ejaz malik et al, Frequency Of Celiac Disease In Type 1 Diabetic Adults., Indo Am. J. P. Sci, 2021; 08(12).
Number of Downloads : 10
References:
1. Cattasi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, et al. Celiac disease in the year 2000: exploring the iceberg. Lancet. 1994;343 (8891):200-203.
2. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med.2002;346(3):180-188.
3. Green PH, Cellier C. Celiac disease. N Engl J Med.2007;357:1731–1743.
4. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not- at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163(3):286-292. doi:10.1001/ archinte.163.3.286.
5. Tatar G, Elsurer R, Simsek H, Balaban YH, Hascelik G, Ozcebe OI, et al. Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population. Dig Dis Sci. 2004;49(9):1479–1484.
6. Walker-Smith JA, Vines R, Grigor W. Coeliac disease and diabetes. Lancet. 1969;2:650–651.
7. Vitoria JC, Castano L, Rica I, Bilbao JR, Arrieta A, Garcia- Masdevall MD. Association of insulin-dependent diabetes mellitus and celiac disease: a study based on serologic markers. J Pediatr Gastroenterol Nutr. 1998;27:47–52.
8. Barera G, Bonfanti R, Viscardi M, Bazzigaluppi E, Calori G, Meschi F, et al. Occurrence of celiac disease after onset of type I diabetes: a 6-year prospective longitudinal study. Pediatrics. 2002;109(5):833–838.
9. Bouguerra R, Ben Salem L, Chaabouni H, Laadhar L, Essais O, Zitouni M, et al. Celiac disease in adult patients with type 1 diabetes mellitus in Tunisia. Diabetes Metab.2005;31:83-86.
10. Aktay AN, Lee PC, Kumar V, Parton E, Wyatt DT, Werlin SL. The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin. J Pediatr Gastroenterol Nutr. 2001;33:462–465.
11. Gillett PM, Gillett HR, Israel DM, Metzger DL, Stewart L, Chanoine JP, et al. High prevalence of celiac disease in patients with type I diabetes detected by antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol. 2001;15:297–301.
12. Guvenc S, Kaymakoglu S, Gurel N, Karsıdag K, Demir K, Dincer D, et al The prevalence of manifest and latent celiac disease in type 1 diabetes mellitus. Turk J Gastroenterol. 2002;13(2):103-107.
13. Shahbazkhani B, Faezi T, Akbari MR, Mohamadnejad M, Sotuudeh M, Rajab A, et al. Celiac disease in Iranian type I diabetic patients. Dig Liv Dis. 2004;36:191-194.
14. Maki M, Collin P. Celiac disease. Lancet.
1997;349:1755 1759.
15. Barker JM. Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab. 2006;91:1210–1217.
16. Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of celiac disease among children in Finland. N Engl J Med. 2003;348:2517–2524.
17. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterol. 1992;102(1):330-354.
18. Gursoy S, Guven K, Simsek T, Yurci A, Torun E, et al. The prevalence of unrecognized adult celiac disease in central Anatolia. J Clin Gastroenterol. 2005;39(6):508.
19. Mansour AA, Najeeb AA. Celiac disease in Iraqi type 1 diabetic patients. Arab J Gastroentrol. 2011;12:103-105. doi:10.1016/j.ajg.2011.04.007
20. Cronin CC, Shanahan F. Insulin dependent diabetes mellitus and coeliac disease. Lancet. 1997;349(12):1096-1097.
21. Trier JS. Diagnosis of celiac sprue. Gastoenterology. 1998;115:211-216.
22. Holmes GKT. Celiac disease and type 1 diabetes mellitus- the case for screening. Diabetic Med. 2001;18:169-177.
23. Volta U, Tovoli F, Caio G. Clinical and immunological features of celiac disease in patients with type 1 diabetes mellitus. Expert Rev Gastroentrol Hepatol. 2011;5:479-487. doi: 10.1586/egh.11.38.